Literature DB >> 2383265

Evidence for an alternate splicing in the thyroperoxidase messenger from patients with Graves' disease.

E Zanelli1, M Henry, B Charvet, Y Malthièry.   

Abstract

An initial lambda gt 11 cDNA library constructed from a human Graves' patient thyroid was screened with an immunopurified rabbit anti-human thyroperoxidase (hTPO) polyclonal antibody. A 869 bp clone was obtained. It presents a 130 bp deletion as compared to the published sequence and a 77 bp insertion in the 3' non-coding region. Screening of a pUC cDNA library from another Graves' patient thyroid exhibited the same 130 bp deletion in two other cDNA clones. PCR analysis of mRNA transcripts confirmed the presence of the two messengers in two other Graves' thyroid tissues. In all the cases, this new spliced mRNA species represents between 40% and 50% of the total hTPO mRNAs. With respect to the structure of the hTPO gene, the present deletion suggests an alternate splicing of exon 16. The juxtaposition of exon 17 to exon 15 encoding the transmembrane domain leads to a shift in the reading frame. By the use of a different stop codon, the spliced mRNA generates a modified 56 - COOH terminal aminoacids (aa) sequence.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2383265     DOI: 10.1016/0006-291x(90)92152-p

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Anti-human thyroid peroxidase and anti-human thyroglobulin antibodies present no cross-reactivity on recombinant peptides.

Authors:  M Henry; E Zanelli; Y Malthiery
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

2.  Phenothiazine-induced increase in thyroid autoantigens and costimulatory molecules on thyroid cells: a pathophysiological mechanism for drug-induced autoimmunity?

Authors:  L Takorabet; A Ropars; L Stasiuk; C Raby; J Charreire
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

3.  Thyroid-specific enhancer-binding protein (T/EBP): cDNA cloning, functional characterization, and structural identity with thyroid transcription factor TTF-1.

Authors:  K Mizuno; F J Gonzalez; S Kimura
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

4.  Use of recombinant epitopes to study the heterogeneous nature of the autoantibodies against thyroid peroxidase in autoimmune thyroid disease.

Authors:  E Zanelli; M Henry; Y Malthiery
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

5.  Clinical, Pathological, and Molecular Studies of Two Families with Iodide Organification Defect.

Authors:  Katia G. M. Rego; Ana Elisa C. Billerbeck; Hector M. Targovnik; Cecilia L. S. Santos; Maria G. Alkmin; Sonia Barbosa; Rosalinda Camargo; Geraldo Medeiros-Neto
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

6.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

7.  Functional analyses of C.2268dup in thyroid peroxidase gene associated with goitrous congenital hypothyroidism.

Authors:  Ching Chin Lee; Fatimah Harun; Muhammad Yazid Jalaludin; Chor Yin Lim; Khoon Leong Ng; Sarni Mat Junit
Journal:  Biomed Res Int       Date:  2014-03-17       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.